CD40 antibody
Quick Overview for CD40 antibody (ABIN610074)
Target
See all CD40 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- CD40 Molecule of about 44 kd.
-
Purification
- Protein A purified
-
Immunogen
-
Murine L cells transfectants expressing human CD40.
Type of Immunogen: Cells -
Isotype
- IgG1
-
-
-
-
Application Notes
-
Approved: ELISA, Flo, Func, IP
Usage: Function: Binding of cross linked BE-1 will partially activate B cells. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 50 mM sodium phosphate, pH 7.5, 100 mM potassium chloride, 150 mM sodium chloride, 0.5 mg/mL Gentamicin sulfate
-
Preservative
- Gentamicin sulfate
-
Precaution of Use
- This product contains Gentamicin sulfate: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Do not freeze.
-
Storage
- 4 °C
-
Storage Comment
- Store at 4°C. Do not freeze.
-
-
-
: "KSR--a regulator and scaffold protein of the MAPK pathway." in: Science's STKE : signal transduction knowledge environment, Vol. 2002, Issue 136, pp. pe28, (2002) (PubMed).
: "Expression of raf family proto-oncogenes in normal mouse tissues." in: Oncogene, Vol. 5, Issue 3, pp. 345-51, (1990) (PubMed).
-
: "KSR--a regulator and scaffold protein of the MAPK pathway." in: Science's STKE : signal transduction knowledge environment, Vol. 2002, Issue 136, pp. pe28, (2002) (PubMed).
-
- CD40
-
Alternative Name
- CD40
-
Background
-
Name/Gene ID: CD40
Family: TNF Receptor
Synonyms: CD40, B-cell surface antigen CD40, B cell-associated molecule, B cell surface antigen CD40, CD40 antigen, CD40 type II isoform, p50, Bp50, CD40L receptor, CDW40, TNFRSF5 -
Gene ID
- 958
-
UniProt
- P25942
-
Pathways
- NF-kappaB Signaling, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Target
-